Literature DB >> 19271262

Abacavir/3TC vs. tenofovir/FTC: interim results from ACTG 5202.

Helmut Albrecht.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19271262

Source DB:  PubMed          Journal:  AIDS Clin Care        ISSN: 1043-1543


× No keyword cloud information.
  3 in total

Review 1.  Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.

Authors:  Maxwell O Akanbi; Kimberly K Scarsi; Kimberly Scarci; Babafemi Taiwo; Robert L Murphy
Journal:  Expert Opin Pharmacother       Date:  2012-01       Impact factor: 3.889

2.  Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).

Authors:  F Touzard Romo; L M Smeaton; T B Campbell; C Riviere; R Mngqibisa; M Nyirenda; K Supparatpinyo; N Kumarasamy; J G Hakim; T P Flanigan
Journal:  HIV Clin Trials       Date:  2014 Nov-Dec

Review 3.  Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection.

Authors:  Rustin D Crutchley; Rakesh C Guduru; Amy M Cheng
Journal:  HIV AIDS (Auckl)       Date:  2016-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.